Cover Image

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

The unprecedent situation generated by the COVID-19 global emergency has prompted us to actively work to fight against this pandemic by searching for repurposable agents among FDA approved drugs to shed light into immediate opportunities for the treatment of COVID-19 patients. In the attempt to proc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tiziana Ginex (Author), Urtzi Garaigorta (Author), David Ramírez (Author), Victoria Castro (Author), Vanesa Nozal (Author), Inés Maestro (Author), Javier García-Cárceles (Author), Nuria E. Campillo (Author), Ana Martinez (Author), Pablo Gastaminza (Author), Carmen Gil (Author)
Format:	Book
Published:	MDPI AG, 2021-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent Antiviral
by: Guillermo H. Jimenez-Aleman, et al.
Published: (2021)

In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins
by: Israa Mohamed Shamkh, et al.
Published: (2021)

Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents
by: Mohammad Z. Ahmed, et al.
Published: (2021)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Mostafa, et al.
Published: (2020)

Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023)

FDA approved ready to use phenylephrine
by: Pradeep Kumar Bhatia, et al.
Published: (2021)

An overview of FDA-approved vaccines & their innovators
by: Rebekah H. Griesenauer, et al.
Published: (2017)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023)

FDA-Approved Oximes and Their Significance in Medicinal Chemistry
by: Jyothi Dhuguru, et al.
Published: (2022)

FDA approval of Pfizer-BioNTech: Evaluating the significance of mRNA vaccine approval
by: Syed Abdullah Monawwer, et al.
Published: (2021)

FDA-approved drugs in 2022: A brief outline
by: Haitham Ahmed Al-Madhagi
Published: (2023)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022)

A Comprehensive Map of FDA-Approved Pharmaceutical Products
by: Hao Zhong, et al.
Published: (2018)

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
by: Ioana Gherghescu, et al.
Published: (2020)

Prior authorization for FDA-approved PARP inhibitors in ovarian cancer
by: Anna Jo Bodurtha Smith, et al.
Published: (2024)

Ebanga™: The most recent FDA-approved drug for treating Ebola
by: Elahe Taki, et al.
Published: (2023)

FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024)

FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS
by: article Editorial
Published: (2024)

THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY
by: article Editorial
Published: (2023)

THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
by: article Editorial
Published: (2024)

THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023)

FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
by: article Editorial
Published: (2024)

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia
by: article Editorial
Published: (2023)

FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024)

FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT)
by: article Editorial
Published: (2024)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023)

FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children
by: article Editorial
Published: (2021)

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021)

Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016-2022)
by: Ghulam Shabir, et al.
Published: (2023)

FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis
by: Davide Benedetto Tiz, et al.
Published: (2022)

Selumetinib-A Comprehensive Review of the New FDA-Approved Drug for Neurofibromatosis
by: Surajit Gorai, et al.
Published: (2024)

Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni.
by: Gordana Panic, et al.
Published: (2015)

A review of FDA approved drugs and their formulations for the treatment of breast cancer
by: Mohini Chaurasia, et al.
Published: (2023)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024)

FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES
by: article Editorial
Published: (2024)

2020 FDA/EMA approvals for new immunotherapy drug technologies and applications
by: Maryam Monajati, et al.
Published: (2021)

FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders
by: Austin Lui, et al.
Published: (2022)

Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation
by: Megan C. Herink, et al.
Published: (2022)

Molecular docking of monkeypox (mpox) virus proteinase with FDA approved lead molecules
by: M.Valan Arasu, et al.
Published: (2023)